5 ms·
It's going to be very interesting to see how the people who insisted on getting off-label prescriptions fare in court.
by anigbrowl 3y ago
It's going to be very interesting to see how the people who insisted on getting off-label prescriptions fare in court.
- lawlessone 3y agoAll the non-diabetics using it will generate great data.. for the rest of us.
- ethanbond 3y agoUnfortunately not really, because the infrastructure that allows us to glean insights from actual healthcare practices is abysmal/nonexistent, at least in the US. It became clear during COVID that a lot of people seem to presume there's some way for researchers to just "look at what's happening," and there isn't.
- nradov 3y agoThere's no nationwide research infrastructure for gleaning insights like that. But large provider organizations have huge patient populations and do a lot of research. They have multiple studies underway for Ozempic and similar drugs.
- seanp2k2 3y agoClinical research trials are a lot more useful as they get a lot more data points from far fewer patients. Not many people want to get blood drawn every week and keep a detailed daily journal about eating and exercise habits.
- ethanbond 3y agoTotally. I didn’t say “it won’t be studied,” I’m saying the data won’t be “great,” as described above.
- anigbrowl 3y agoThat's a really good point, and it seems to pervade the scientific establishment. There's an unfortunate tendency to study something, and (assuming a real effect is found & reproduced) say 'well we know about that now' and just move onto something else, instead of building out infrastructure to gather more longitudinal/geographic data. The efforts in the UK to build huge datasets for long-term diagnostics is a welcome exception.
- adrr 3y agoWegovy is incorrectly listed in the article as a diabetes medication, it is only approved for weight loss. It is also 30% more expensive. https://www.wegovy.com/ https://www.wegovy.com/
- belltaco 3y agoWegovy, Ozempic and Rybelsus are all brand names for the same underlying drug semaglitude that was approved first for diabetes in different dosages.
- shadowtree 3y agoWegovy and Ozempic are indication-specific brands, but the same product. Mounjaro by Lilly is still diabetets only, wonder what their obesity-specific brand name will be.
- nradov 3y agoWhen it comes to prescription drug liability claims, it doesn't really matter whether the use was off-label. The key factor is whether harmful side effects were properly disclosed on the product label. Where manufacturers really get hit with huge verdicts is when they knew (or should have known) about a side effect but failed to put it on the label.